| Dr Wade G Swenson, MD | |
|
560 S Maple St Ste 40, Waconia, MN 55387-1759 | |
| (952) 925-5626 | |
| (952) 925-0223 |
| Full Name | Dr Wade G Swenson |
|---|---|
| Gender | Male |
| Speciality | Otolaryngology |
| Experience | 13 Years |
| Location | 560 S Maple St Ste 40, Waconia, Minnesota |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1669766333 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Y00000X | Otolaryngology | 61213 (Minnesota) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Ridgeview Medical Center | Waconia, MN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Ridgeview Medical Center | 9234041997 | 193 |
News Archive
MAXIMUS, Inc., a leading provider of government services worldwide, announced that its Canadian business unit DeltaWare Systems was awarded a contract with the Government of Nova Scotia for the implementation of its Medigent Drug Information System.
Patients who experience chest pain in the 24 hours preceding a heart attack, also called preinfarction angina, have smaller heart attacks and improved cardiac function in the contemporary cardiac stenting era, researchers found in a study published Jan. 22 in Circulation: Cardiovascular Interventions.
A rare congenital genetic mutation means that those affected do not feel pain. However, what seems, at first sight, to be a blessing, can have serious consequences. It means that injuries or diseases can go undetected for a long time. The affected gene was identified by an international research team from MedUni Vienna, the University of Munich and the University of Cambridge.
Atacama Labs Oy has developed an innovative oral drug delivery technology (called 'pneumatic dry granulation' or 'PDG Technology(TM)'). The technology is aimed to replace existing solid dosage form development and manufacturing methods (like wet granulation or standard roller compaction) and will help both NCE galenic developers and life cycle managers to overcome development or differentiation issues.
› Verified 2 days ago
| Entity Name | Ridgeview Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1528364429 PECOS PAC ID: 9234041997 Enrollment ID: O20031111000183 |
News Archive
MAXIMUS, Inc., a leading provider of government services worldwide, announced that its Canadian business unit DeltaWare Systems was awarded a contract with the Government of Nova Scotia for the implementation of its Medigent Drug Information System.
Patients who experience chest pain in the 24 hours preceding a heart attack, also called preinfarction angina, have smaller heart attacks and improved cardiac function in the contemporary cardiac stenting era, researchers found in a study published Jan. 22 in Circulation: Cardiovascular Interventions.
A rare congenital genetic mutation means that those affected do not feel pain. However, what seems, at first sight, to be a blessing, can have serious consequences. It means that injuries or diseases can go undetected for a long time. The affected gene was identified by an international research team from MedUni Vienna, the University of Munich and the University of Cambridge.
Atacama Labs Oy has developed an innovative oral drug delivery technology (called 'pneumatic dry granulation' or 'PDG Technology(TM)'). The technology is aimed to replace existing solid dosage form development and manufacturing methods (like wet granulation or standard roller compaction) and will help both NCE galenic developers and life cycle managers to overcome development or differentiation issues.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Wade G Swenson, MD 500 S Maple St, Waconia, MN 55387-1752 Ph: () - | Dr Wade G Swenson, MD 560 S Maple St Ste 40, Waconia, MN 55387-1759 Ph: (952) 925-5626 |
News Archive
MAXIMUS, Inc., a leading provider of government services worldwide, announced that its Canadian business unit DeltaWare Systems was awarded a contract with the Government of Nova Scotia for the implementation of its Medigent Drug Information System.
Patients who experience chest pain in the 24 hours preceding a heart attack, also called preinfarction angina, have smaller heart attacks and improved cardiac function in the contemporary cardiac stenting era, researchers found in a study published Jan. 22 in Circulation: Cardiovascular Interventions.
A rare congenital genetic mutation means that those affected do not feel pain. However, what seems, at first sight, to be a blessing, can have serious consequences. It means that injuries or diseases can go undetected for a long time. The affected gene was identified by an international research team from MedUni Vienna, the University of Munich and the University of Cambridge.
Atacama Labs Oy has developed an innovative oral drug delivery technology (called 'pneumatic dry granulation' or 'PDG Technology(TM)'). The technology is aimed to replace existing solid dosage form development and manufacturing methods (like wet granulation or standard roller compaction) and will help both NCE galenic developers and life cycle managers to overcome development or differentiation issues.
› Verified 2 days ago
John W Larsen, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 490 S Maple St, Suite 205, Waconia, MN 55387 Phone: 952-925-5626 Fax: 952-442-2180 | |
John W Meccia, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 490 S Maple St, Suite 205, Waconia, MN 55387 Phone: 952-925-5626 |